Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,956 public trials 1,517 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo

NCT01512173

Conditions
Hemangioma, Hemangioma, Capillary, Infantile Hemangioma, +3 more
Locations
  • CHU Bordeaux Hôpital Pellegrin-Enfants - Unité de Dermatologie pédiatrique Bordeaux, France
  • Hôpital Saint Vincent de Paul - Dermatologie Pédiatrique Lille, France
  • CHU Lyon Est Hôpital mère enfant - Consultation des angiomes Lyon Bron, France
  • CHU Timone - Service de dermatologie Marseille, France
View all 17 locations
View Trial Details
Completed

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

NCT01455532

Conditions
Neoplasm Malignant, Neoplasms
Locations
  • Investigational Site Number 840002 Scottsdale, Arizona, United States
  • Investigational Site Number 840004 Los Angeles, California, United States
  • Investigational Site Number 840010 Augusta, Georgia, United States
  • Investigational Site Number 840007 St Louis, Missouri, United States
View Trial Details
Completed

A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

NCT01246960

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anchorage, Alaska, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alhambra, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
View all 58 locations
View Trial Details
Completed

Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy

NCT00627042

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Chicago, Illinois, United States
  • ImClone Investigational Site Metairie, Louisiana, United States
  • ImClone Investigational Site Boston, Massachusetts, United States
View Trial Details

Related conditions